Delving into the Latest Updates on Qingdao Institute of Marine Biomedicine with Synapse

Overview

Tags

Neoplasms

Small molecule drug

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

No Data

Disease Domain	Count

Neoplasms	1

Top 5 Drug Type	Count

Small molecule drug	1

主要目的：评估注射用BG136在健康受试者中单次和多次静脉滴注给药的安全性和耐受性。次要目的：评估健康受试者单次和多次静脉滴注注射用BG136的药代动力学（PK）和药效动力学（PD）特征；评估注射用BG136在健康受试者体内安全有效的剂量范围，为Ⅱ期临床研究的给药方案提供依据；评估注射用BG136在健康受试者体内免疫原性。

[Translation]

Primary objective: To evaluate the safety and tolerability of single and multiple intravenous infusions of BG136 for injection in healthy subjects. Secondary objectives: To evaluate the pharmacokinetic (PK) and pharmacodynamic (PD) characteristics of single and multiple intravenous infusions of BG136 for injection in healthy subjects; To evaluate the safe and effective dose range of BG136 for injection in healthy subjects, and provide a basis for the dosing regimen of Phase II clinical studies; To evaluate the immunogenicity of BG136 for injection in healthy subjects.

Start Date19 Aug 2023

Sponsor / Collaborator

Ocean University of China

[+2]

100 Clinical Results associated with Qingdao Institute of Marine Biomedicine

Login to view more data

0 Patents (Medical) associated with Qingdao Institute of Marine Biomedicine

Login to view more data

100 Deals associated with Qingdao Institute of Marine Biomedicine

Login to view more data

100 Translational Medicine associated with Qingdao Institute of Marine Biomedicine

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 23 Dec 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

IND Approval

1

Phase 1 Clinical

Login to view more data